-
Signature
-
/s/ Avraham S. Adler, Attorney-in-Fact
-
Issuer symbol
-
PTCT
-
Transactions as of
-
08 Sep 2025
-
Net transactions value
-
-$1,362,147
-
Form type
-
4
-
Filing time
-
09 Sep 2025, 17:00:06 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Pauwels Eric |
CHIEF BUSINESS OFFICER |
C/O PTC THERAPEUTICS, INC., 500 WARREN CORPORATE CENTER DRIVE, WARREN |
/s/ Avraham S. Adler, Attorney-in-Fact |
09 Sep 2025 |
0001323212 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$515,300 |
+16,698 |
+23% |
$30.86 |
89,610 |
08 Sep 2025 |
Direct |
F1, F2 |
| transaction |
PTCT |
Common Stock |
Sale |
$950,784 |
-16,698 |
-19% |
$56.94 |
72,912 |
08 Sep 2025 |
Direct |
F1, F3 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$67,571 |
+6,017 |
+8.3% |
$11.23 |
78,929 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$342,427 |
-6,017 |
-7.6% |
$56.91 |
72,912 |
08 Sep 2025 |
Direct |
F1, F4 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$153,589 |
+8,528 |
+12% |
$18.01 |
81,440 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$485,414 |
-8,528 |
-10% |
$56.92 |
72,912 |
08 Sep 2025 |
Direct |
F1, F5 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$114,583 |
+3,713 |
+5.1% |
$30.86 |
76,625 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$211,344 |
-3,713 |
-4.8% |
$56.92 |
72,912 |
08 Sep 2025 |
Direct |
F1, F6 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$27,019 |
+2,406 |
+3.3% |
$11.23 |
75,318 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$136,950 |
-2,406 |
-3.2% |
$56.92 |
72,912 |
08 Sep 2025 |
Direct |
F1, F7 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$14,014 |
+1,238 |
+1.7% |
$11.32 |
74,150 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$70,380 |
-1,238 |
-1.7% |
$56.85 |
72,912 |
08 Sep 2025 |
Direct |
F1, F8 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$14,150 |
+1,250 |
+1.7% |
$11.32 |
74,162 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$71,075 |
-1,250 |
-1.7% |
$56.86 |
72,912 |
08 Sep 2025 |
Direct |
F1, F9 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-16,698 |
-82% |
$0.000000 |
3,713 |
08 Sep 2025 |
Common Stock |
16,698 |
$30.86 |
Direct |
F1, F10 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-6,017 |
-71% |
$0.000000 |
2,406 |
08 Sep 2025 |
Common Stock |
6,017 |
$11.23 |
Direct |
F1, F10 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-8,528 |
-100% |
$0.000000 |
0 |
08 Sep 2025 |
Common Stock |
8,528 |
$18.01 |
Direct |
F1, F10 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-3,713 |
-100% |
$0.000000 |
0 |
08 Sep 2025 |
Common Stock |
3,713 |
$30.86 |
Direct |
F1, F10 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,406 |
-100% |
$0.000000 |
0 |
08 Sep 2025 |
Common Stock |
2,406 |
$11.23 |
Direct |
F1, F10 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-1,238 |
-50% |
$0.000000 |
1,250 |
08 Sep 2025 |
Common Stock |
1,238 |
$11.32 |
Direct |
F1, F10 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-1,250 |
-100% |
$0.000000 |
0 |
08 Sep 2025 |
Common Stock |
1,250 |
$11.32 |
Direct |
F1, F10 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: